We appreciate FDA’s support in designating REVASCOR both RMAT and RPD status, a recognition of the potential impact of our therapy on the long-term adverse outcomes of these desperately ill children.
These shares are having a tough time on Thursday. What's going on? The post Why 29Metals, Guzman Y Gomez, Mesoblast, and Pilbara Minerals shares are falling today appeared first on The Motley Fool ...